imagine the scramble when the drug we started developing with Amring gets disclosed. A drug with US$400 million in yearly sales ( reportedly) . And why did Amring pull out of the deal? I hope it wasn’t to take what it’s learned to date and develop their own version. Because Amring have pulled out what stops them disclosing the drug to others? When something like this happens my suspicions are heightened as was joining ACR just a ploy to find out what we’re doing? For $300,000 thousand they get a heads up on the major seller.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.366M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 883823 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 500697 | 1 |
View Market Depth
| Last trade - 16.21pm 30/07/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable